Nandroxyl 250

KALPA PHARMACEUTICALS NANDROXYL 250

Nandroxyl 250, manufactured by Kalpa Pharmaceuticals, is a powerful anabolic steroid containing Nandrolone Decanoate as its active ingredient. This formulation is designed to provide sustained release and long-lasting effects.

DRUG COMPOSITION

Each vial of Nandroxyl 250 contains:

• Nandrolone Decanoate 250 mg/mL

PHARMACEUTICAL FORM

Nandroxyl 250 is formulated as an injectable solution for intramuscular administration.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Anabolic steroids; ATC code: A14A B01.

PHARMACOLOGICAL PROPERTIES

Nandrolone Decanoate is a versatile androgen with strong anabolic properties. It promotes nitrogen retention, enhances protein synthesis, and increases red blood cell production, contributing to muscle growth and improved endurance.

PROFILE

• Chemical name: (17ОІ)-3-Oxoestr-4-en-17-yl decanoate
• Chemical formula: C28H44O3
• Percentage of anabolic activity: 125.00%
• Percentage of androgenic activity: 37.00%
• Active half life: Approximately 6-15 days
• Recommended dosage: 300-600 mg/week
• Acne: Possible
• Bloating (water retention): Possible
• HBR: Low
• Hepatic toxicity: Low
• Aromatization: Moderate

THERAPEUTICAL INDICATIONS

Nandroxyl 250 is indicated in conditions requiring enhanced protein synthesis and increased bone density. It is commonly used in the treatment of anemia, muscle wasting diseases, and osteoporosis.

DOSES AND METHOD OF ADMINISTRATION

Dosage and administration should be determined by a healthcare professional. Nandroxyl 250 is typically administered via intramuscular injection.

CYCLE/STACKING

Solo cycle:

• Weeks 1-12: Nandroxyl 250 (250 mg per week)

Cutting cycle:

• Weeks 1-10: Nandroxyl 250 (250 mg per week)
• Weeks 6-12: Stanoxyl 50 (50 mg every other day)

Bulking cycle:

• Weeks 1-12: Nandroxyl 250 (250 mg per week)
• Weeks 1-6: Dianoxyl 20 (20 mg daily)

POST CYCLE THERAPY

PCT after a cycle with Nandroxyl 250:

• Weeks 1-4: Clomixyl (50 mg daily)
• Weeks 1-4: Nolvaxyl (20 mg daily)

SIDE EFFECTS

Potential side effects may include bloating, acne, increased blood pressure, and suppressed natural testosterone production.

CONTRAINDICATIONS

Nandroxyl 250 is contraindicated in individuals with a known hypersensitivity to Nandrolone Decanoate and those with a history of prostate or breast cancer.

OVERDOSE

In the case of an overdose, seek immediate medical attention. Symptoms may include nausea, vomiting, and changes in skin color.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Use with caution in patients with cardiovascular, hepatic, or renal impairment. Regular monitoring of lipid profiles and blood pressure is recommended.

INTERACTIONS WITH OTHER DRUGS

Nandroxyl 250 may interact with anticoagulants, insulin, and other anabolic steroids. Inform healthcare providers of all medications being taken.

PRESENTATION, PACKAGING

250 mg/mL in 10 mL vials.

STORAGE

Store Nandroxyl 250 at room temperature, protected from light and moisture. Keep it out of reach of children.

LEGAL STATUS

Nandroxyl 250 is available only with a prescription and is subject to the regulations of each jurisdiction.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Kalpa Pharmaceuticals
India

EXTERNAL LINKS

• Nandrolone Decanoate Wiki, wikipedia.org
• Nandrolone: Package Insert, drugs.com
• Nandrolone Decanoate: Use, Abuse and Side Effects, ncbi.nlm.nih.gov.